Mylan 2Q profit drops 30 percent

SHARE Mylan 2Q profit drops 30 percent

Mylan Inc. on Thursday reported profit that declined by 30 percent in its second quarter, and missed analysts’ expectations.

The Canonsburg, Pennsylvania-based company in July announced a $5.3 billion deal to buy Abbott Laboratories’ generic drugs business in developed markets. The combined company will be based in the Netherlands for tax purposes. Mylan is buying more than 100 generic and specialty drugs that had sales of about $2 billion in sales last year.

Mylan said its second-quarter net income fell to $125.2 million, or 32 cents per share, from $177.7 million, or 46 cents per share, in the same quarter a year earlier.

Earnings, adjusted for one-time gains and costs, came to 69 cents per share. The average estimate of analysts surveyed by Zacks Investment Research was for earnings of 70 cents per share.

The generic drugmaker said revenue rose 8 percent to $1.84 billion from $1.7 billion in the same quarter a year earlier, and missed Wall Street forecasts. Analysts expected $1.9 billion, according to Zacks.

Mylan shares have risen $4.52, or 10 percent, to $47.92 since the beginning of the year, while the Standard & Poor’s 500 index has climbed almost 4 percent.

The Latest
Mexican Independence Day celebrations offer a glimpse of the size and growth of the community in the Chicago area.
While Texans fans can dare to dream with Stroud showing early flashes — 280 passing yards and a 118.7 rating in an upset of the Jaguars — Bears fans are left with an age-old lament: Why is developing a quarterback at Halas Hall always like pulling teeth?
The All-Star center fielder lands on the injured list with a sprained left knee; White Sox recall OF Tyler Naquin from Charlotte.
The complaint is the result of a years-long investigation into Amazon’s businesses and one of the most significant legal challenges brought against the company in its nearly 30-year history.
The final phase begins in October with the replacement of northbound tracks between Belmont and Cornelia avenues. Construction goes through 2025.